Summit is an AIM listed UK based drug discovery company targeting therapeutic sectors with high unmet clinical need as well as an innovative Seglin ™ technology platform and a portfolio licensed drug candidates that has already generated revenues of at least GBP5 million. Summit is an unusual biopharma play because it does not follow the […]